Peter Attia· MD
before 2011 um the fda you know the definition of alzheimer's was dementia so there was no place in research for these prodromal patients or you know testing these interventions in people before they had full-blown dementia
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
before 2011 um the fda you know the definition of alzheimer's was dementia so there was no place in research for these prodromal patients or you know testing these interventions in people before they had full-blown dementia
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
before 2011 — the fda you know the definition of alzheimer's was dementia so there was no place in research for these prodromal patients or you know testing these interventions in people before they had full-blown dementia and that was very much like waiting until someone had a heart attack to say that they had coronary artery disease